These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 11889437)

  • 1. Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients.
    Belperio JA; DiGiovine B; Keane MP; Burdick MD; Ying Xue Y; Ross DJ; Lynch JP; Kunkel SL; Strieter RM
    Transplantation; 2002 Feb; 73(4):591-9. PubMed ID: 11889437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant.
    Riise GC; Andersson BA; Kjellström C; Martensson G; Nilsson FN; Ryd W; Scherstén H
    Eur Respir J; 1999 Nov; 14(5):1123-30. PubMed ID: 10596701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation.
    Fisichella PM; Davis CS; Lowery E; Ramirez L; Gamelli RL; Kovacs EJ
    J Am Coll Surg; 2013 Jul; 217(1):90-100; discussion 100-1. PubMed ID: 23628225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased serum and bronchoalveolar lavage levels of Clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients.
    Nord M; Schubert K; Cassel TN; Andersson O; Riise GC
    Transplantation; 2002 Apr; 73(8):1264-9. PubMed ID: 11981419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
    Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
    Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group.
    Elssner A; Jaumann F; Dobmann S; Behr J; Schwaiblmair M; Reichenspurner H; Fürst H; Briegel J; Vogelmeier C
    Transplantation; 2000 Jul; 70(2):362-7. PubMed ID: 10933164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation.
    D'Ovidio F; Mura M; Tsang M; Waddell TK; Hutcheon MA; Singer LG; Hadjiliadis D; Chaparro C; Gutierrez C; Pierre A; Darling G; Liu M; Keshavjee S
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1144-52. PubMed ID: 15867792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-13 is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome.
    Keane MP; Gomperts BN; Weigt S; Xue YY; Burdick MD; Nakamura H; Zisman DA; Ardehali A; Saggar R; Lynch JP; Hogaboam C; Kunkel SL; Lukacs NW; Ross DJ; Grusby MJ; Strieter RM; Belperio JA
    J Immunol; 2007 Jan; 178(1):511-9. PubMed ID: 17182591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration.
    Reynaud-Gaubert M; Marin V; Thirion X; Farnarier C; Thomas P; Badier M; Bongrand P; Giudicelli R; Fuentes P
    J Heart Lung Transplant; 2002 Jul; 21(7):721-30. PubMed ID: 12100898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients.
    Neurohr C; Huppmann P; Samweber B; Leuschner S; Zimmermann G; Leuchte H; Baumgartner R; Hatz R; Frey L; Ueberfuhr P; Bittmann I; Behr J;
    J Heart Lung Transplant; 2009 May; 28(5):468-74. PubMed ID: 19416775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron overload and nitric oxide-derived oxidative stress following lung transplantation.
    Reid D; Snell G; Ward C; Krishnaswamy R; Ward R; Zheng L; Williams T; Walters H
    J Heart Lung Transplant; 2001 Aug; 20(8):840-9. PubMed ID: 11502406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchoalveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to onset of bronchiolitis obliterans syndrome.
    Meloni F; Vitulo P; Cascina A; Oggionni T; Bulgheroni A; Paschetto E; Klersy C; D'Armini AM; Fietta A; Bianco AM; Arbustini E; Viganò M
    J Heart Lung Transplant; 2004 Sep; 23(9):1053-60. PubMed ID: 15454171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients.
    Mamessier E; Milhe F; Badier M; Thomas P; Magnan A; Reynaud-Gaubert M
    J Heart Lung Transplant; 2006 May; 25(5):523-32. PubMed ID: 16678030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of IL-26 in bronchiolitis obliterans syndrome but not in acute rejection after lung transplantation.
    Magnusson JM; Ericson P; Tengvall S; Stockfelt M; Brundin B; Lindén A; Riise GC
    Respir Res; 2022 May; 23(1):108. PubMed ID: 35501858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung.
    Riise GC; Williams A; Kjellström C; Schersten H; Andersson BA; Kelly FJ
    Eur Respir J; 1998 Jul; 12(1):82-8. PubMed ID: 9701419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential cytokine, chemokine and growth factor expression in phenotypes of chronic lung allograft dysfunction.
    Verleden SE; Ruttens D; Vos R; Vandermeulen E; Moelants E; Mortier A; Van Raemdonck DE; Proost P; Schols D; Verleden GM; Vanaudenaerde BM
    Transplantation; 2015 Jan; 99(1):86-93. PubMed ID: 25050473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of alveolar macrophage production of tumor necrosis factor-alpha and interleukin-6 in lung transplant recipients. Marseille and Montreal Lung Transplantation Group.
    Magnan A; Mege JL; Reynaud M; Thomas P; Capo C; Garbe L; Meric B; Badier M; Bongrand P; Viard L
    Am J Respir Crit Care Med; 1994 Sep; 150(3):684-9. PubMed ID: 8087338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?
    Moffatt-Bruce SD; Karamichalis J; Robbins RC; Whyte RI; Theodore J; Reitz BA
    Ann Thorac Surg; 2006 Jan; 81(1):286-91; discussion 291. PubMed ID: 16368382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings.
    Reynaud-Gaubert M; Thomas P; Badier M; Cau P; Giudicelli R; Fuentes P
    Am J Respir Crit Care Med; 2000 Jun; 161(6):1924-9. PubMed ID: 10852768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchoalveolar lavage fluid characteristics in acute and chronic lung transplant rejection.
    Slebos DJ; Postma DS; Koëter GH; Van Der Bij W; Boezen M; Kauffman HF
    J Heart Lung Transplant; 2004 May; 23(5):532-40. PubMed ID: 15135367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.